Arrowstreet Capital, Limited Partnership Veru Inc. Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $97,735 - $356,117	22,468 New	22,468 $254,000
Q1 2021 May 14, 2021	SELL	$8.05 - $20.78 $821,454 - $2.12 Million	-102,044 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.36 - $9.99 $678,780 - $2.87 Million	-287,619 Reduced 73.81%	102,044 $883,000
Q3 2020 Nov 12, 2020	BUY	$2.58 - $3.36 $53,124 - $69,185	20,591 Added 5.58%	389,663 $1.02 Million
Q2 2020 Aug 12, 2020	BUY	$3.01 - $4.02 $1.11 Million - $1.48 Million	369,072 New	369,072 $1.23 Million

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.